108 BioCapital Invests $4 Million in SedMed for Expanding Accessibility Solutions

108 BioCapital's Strategic Investment in SedMed, Inc.

On October 1, 2026, 108 BioCapital revealed its role in leading a financing round for SedMed, Inc., with a significant investment of $4 million. This financial backing is set to propel SedMed’s growth trajectory, particularly in expanding access to its innovative non-electric toilet lift designed for older adults and individuals facing mobility limitations. The toilet lift assists users in sitting down and standing up safely without requiring electrical power, thereby addressing a critical need for independence and caregiver support.

SedMed is a pioneering company dedicated to creating medical devices that enhance mobility for people who struggle with conventional bathroom installations. The company’s flagship product, the SedMed Toilet Lift, seamlessly attaches to most standard toilets and offers adjustable support for transitioning from sitting to standing, promoting user safety and minimizing physical stress on caregivers. The product stands out because it does not rely on electricity or batteries, ensuring versatility across various settings and reducing the need for extensive bathroom modifications.

Addressing Key Healthcare Challenges

Sasha Bakhru, Managing Partner at 108 BioCapital, emphasizes the importance of SedMed's mission: "SedMed is tackling an often-overlooked challenge faced by seniors and individuals with limited mobility, along with their caregivers. The company has created an intuitive, non-electric device that can significantly enhance safety, maintain independence, and lower the burden on those who provide care."

The investment from 108 BioCapital will enable SedMed to accelerate its commercial efforts, widen its distribution partnerships, expand its intellectual property portfolio, and conduct vital hospital-based studies to underline the value of its products. Shahryar Oveissi, General Partner at 108 BioCapital, notes, “SedMed's adoption by over 40 hospital systems shows a strong market demand for its solutions, underscoring their potential to make a difference for healthcare providers and patients alike.”

Global Market Potential

Moreover, there appears to be a promising opportunity for SedMed beyond the United States. Shom Jagtiani, another General Partner at 108 BioCapital, identified significant potential in markets like India, where the non-electric design can enhance safety and independence for older adults in both home and healthcare environments. Jagtiani highlighted the practicality of SedMed's products, suggesting their deployment could revolutionize bathroom mobility solutions internationally and address crucial issues faced by senior citizens in developing regions.

Future Directions for SedMed

Jeremy Bronen, CEO of SedMed, expressed his enthusiasm regarding this investment, framing it as a pivotal moment for the company. “This funding will allow us to significantly enhance our commercial footprint, improve our distribution networks, and gather more evidence to show how our products can uphold the safety and dignity of users,” he stated. SedMed is committed to advancing its mission of making bathroom mobility solutions accessible, fostering safer lifestyles for individuals with mobility challenges, and easing the strain on caregivers.

About SedMed and 108 BioCapital

SedMed, based in Milford, Connecticut, designs its products with the goal of combining functionality with user-centered design in the realm of medical devices. Their mission is to foster independence and improve safety in bathroom mobility for those with mobility limitations. On the other hand, 108 BioCapital focuses on investing in growth-stage companies within the biotech and medtech arenas that aim to address pressing unmet medical needs. Their investment marks a strategic effort to enhance healthcare solutions by investing in advanced technologies.

As SedMed moves forward with this new funding, it is set to reinforce its role in the healthcare market, developing solutions that not only enhance mobility but also align with broader social goals of health independence and dignity for aging populations.